View in EDS

Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label Study.

Saved in:
Bibliographic Details
Title: Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label Study.
Authors: Cheng MP; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.; Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada.; McGill Interdisciplinary Initiative in Infection and Immunity, McGill University, Montreal, Quebec, Canada., Gonzalez-Bocco IH; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Arbonna-Haddad E; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA., Aleissa M; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia., Chen K; Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA., Zhou E; Case Western Reserve University School of Medicine, Cleveland, OH, USA., Beluch K; Thomas Jefferson University, Philadelphia, PA, USA., Cho A; University of the Pacific, Arthur A. Dugoni School of Dentistry, San Francisco, CA, USA., Burchett S; Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA., Moulton E; Division of Infectious Diseases, Texas Children's Hospital, Houston, TX, USA., Desjardins M; Divisions of Infectious Diseases and Medical Microbiology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada., Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Koo S; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Letourneau AR; Harvard Medical School, Boston, MA, USA.; Divisions of Infectious Diseases and Hematology Oncology, Massachusetts General Hospital, Boston, MA, USA., Hammond SP; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Divisions of Infectious Diseases and Hematology Oncology, Massachusetts General Hospital, Boston, MA, USA., Ritz J; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Soiffer R; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Issa NC; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Sherman AC; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Source: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada [J Assoc Med Microbiol Infect Dis Can] 2025 Jan 20; Vol. 10 (1), pp. 6-14. Date of Electronic Publication: 2025 Jan 20 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: University of Toronto Press Country of Publication: Canada NLM ID: 101763536 Publication Model: eCollection Cited Medium: Internet ISSN: 2371-0888 (Electronic) Linking ISSN: 23710888 NLM ISO Abbreviation: J Assoc Med Microbiol Infect Dis Can Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40671855
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cheng+MP%22">Cheng MP</searchLink>; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.; Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada.; McGill Interdisciplinary Initiative in Infection and Immunity, McGill University, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Bocco+IH%22">Gonzalez-Bocco IH</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Arbonna-Haddad+E%22">Arbonna-Haddad E</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Aleissa+M%22">Aleissa M</searchLink>; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+E%22">Zhou E</searchLink>; Case Western Reserve University School of Medicine, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Beluch+K%22">Beluch K</searchLink>; Thomas Jefferson University, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cho+A%22">Cho A</searchLink>; University of the Pacific, Arthur A. Dugoni School of Dentistry, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Burchett+S%22">Burchett S</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moulton+E%22">Moulton E</searchLink>; Division of Infectious Diseases, Texas Children's Hospital, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Desjardins+M%22">Desjardins M</searchLink>; Divisions of Infectious Diseases and Medical Microbiology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Baden+LR%22">Baden LR</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Koo+S%22">Koo S</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Letourneau+AR%22">Letourneau AR</searchLink>; Harvard Medical School, Boston, MA, USA.; Divisions of Infectious Diseases and Hematology Oncology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hammond+SP%22">Hammond SP</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Divisions of Infectious Diseases and Hematology Oncology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ritz+J%22">Ritz J</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Soiffer+R%22">Soiffer R</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Issa+NC%22">Issa NC</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+HT%22">Kim HT</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sherman+AC%22">Sherman AC</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101763536%22">Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada</searchLink> [J Assoc Med Microbiol Infect Dis Can] 2025 Jan 20; Vol. 10 (1), pp. 6-14. <i>Date of Electronic Publication: </i>2025 Jan 20 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22University+of+Toronto+Press%22">University of Toronto Press </searchLink><i>Country of Publication: </i>Canada <i>NLM ID: </i>101763536 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2371-0888 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223710888%22">23710888 </searchLink><i>NLM ISO Abbreviation: </i>J Assoc Med Microbiol Infect Dis Can <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40671855
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3138/jammi-2024-0016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6
    Titles:
      – TitleFull: Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cheng MP
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Bocco IH
      – PersonEntity:
          Name:
            NameFull: Arbonna-Haddad E
      – PersonEntity:
          Name:
            NameFull: Aleissa M
      – PersonEntity:
          Name:
            NameFull: Chen K
      – PersonEntity:
          Name:
            NameFull: Zhou E
      – PersonEntity:
          Name:
            NameFull: Beluch K
      – PersonEntity:
          Name:
            NameFull: Cho A
      – PersonEntity:
          Name:
            NameFull: Burchett S
      – PersonEntity:
          Name:
            NameFull: Moulton E
      – PersonEntity:
          Name:
            NameFull: Desjardins M
      – PersonEntity:
          Name:
            NameFull: Baden LR
      – PersonEntity:
          Name:
            NameFull: Koo S
      – PersonEntity:
          Name:
            NameFull: Letourneau AR
      – PersonEntity:
          Name:
            NameFull: Hammond SP
      – PersonEntity:
          Name:
            NameFull: Ritz J
      – PersonEntity:
          Name:
            NameFull: Soiffer R
      – PersonEntity:
          Name:
            NameFull: Issa NC
      – PersonEntity:
          Name:
            NameFull: Kim HT
      – PersonEntity:
          Name:
            NameFull: Sherman AC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 01
              Text: 2025 Jan 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2371-0888
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada
              Type: main
ResultId 1